The relation between survival and histological features in 91 patients with malignant melanoma was studied and the results were analysed by Clayton's method for interpretation of censored survival data. There was a significant correlation between tumour thickness and survival. The risk of dying from malignant melanoma after 10 years of follow up was less than 15% if the primary tumour was less than 1 5 mm thick but more than 80% if the lesion was thicker than 8 mm.
The clinical course of cutaneous malignant melanoma is variable.' ' Some patients are apparently cured by simple excision but similar treatment in others is followed by the development of metastases and early death. This had led to investigation of histological features which may have prognostic significance. The histological type of melanoma"X mitotic rate," extent of dermal invasion (Clark's level),-'4 '°d egree of lymphocytic infiltration '2" and the presence of ulceration8 ""4 have all been shown to correlate with survival. Interpretation of some of these features is subjective and although they have statistical meaning their value when dealing with individual patients is often doubtful. A more objective measurement is necessary to help predict prognosis. Breslow'" measured the diameter, thickness and volume of cutaneous melanomas and established that the thickness of the neoplasm, irrespective of its type, diameter or calculated volume, was a useful guide to subsequent behaviour. Further study of series of melanoma patients in America,'4 Canada,'3 Australia9 and Scandinavia'6 have confirmed this finding but there is still need to define the risks of death or tumour recurrence in relation to various thickness bands. We have conducted a retrospective study of patients with malignant melanoma to assess the value of tumour thickness and other histological features in predicting the outcome of the disease.
Accepted for publication 29 June 1982 Patients and methods Tumour thickness A Joyce Loebl "Magiscan" image analysis system was used to measure the thickness of each tumour using an interactive programme (Fig. 1) 
PATIENTS

Results
Twenty-six patients were men, with an average age of 49 yr; 65 were women with an average age of 50 yr (Fig. 2 ). The lower limb was the commonest site in females, and the trunk in males (Fig. 3) . In most patients the initial treatment consisted of surgical excision, with or without skin grafting.
Thirty-four of the 91 patients died from metastatic malignant melanoma at times ranging from seven to 108 months after presentation (mean = 33 months). Not all the patients were followed up for the same length of time-that is, the data was "censored." However, Clayton's method20 takes censoring into account when the death-rate model is fitted to the observed data.
Tumour thickness Survival was closely associated with the thickness of the primary melanoma (Table 1) . The model for death-rates fitted the data well, the constants ,3, and 1,3 were significantly different from 0 (p < 0-01) ( presentation: during those years those with 2 5 mm and 8 mm tumours had recurrence risks of 17% and 40% respectively (Fig. 4) .
Level ofinvasion
The level of invasion of a melanoma into the dermis correlated with survival (Table 4 ). All six patients with tumours graded as level I survived, whilst six of nine patients with level V melanomas died. Most patients had neoplasms in level III or IV and in these groups the chance of survival was slightly greater than 50% after an average of nearly seven years of followup. The level of invasion was also related to tumour thickness. All level I were less than 1 mm thick; only two level II melanomas were thicker than 2 mm but all level V melanomas were thicker than 3 mm (Fig. 6 ).
Mitotic rate
There is an association between frequency of mitoses and crude survival rate (Table 5) , but there is a significant correlation between tumour thickness and mitotic rate (Fig. 7) .
Lymphocyte infiltration There was no significant correlation between survival and degree of lymphocytic infiltration nor between inflammation and thickness. 
Other histologicalfeatures
Fifty-three of the melanomas were nodular and 36 were of superficial spreading type. Two were unclassifiable. The survival rate was higher for patients with superficial spreading melanomas (69-4%) than for those with nodular melanomas (59-6%). However the average thickness of the former (2-65 mm) was less than that of nodular melanomas (4-03 mm). Only 27% of superficial spreading melanomas were more than 3 mm thick compared to 58% of nodular melanoma.
Forty-one tumours were ulcerated and this was survival in 44 patients with primary melanoma < 1 mm thick. Eldh et a15 reported a greater than 90% survival in 180 patients with tumours < 1 5 mm. Thus although there are differences in the reported figures, it is generally agreed that patients with melanomas less than 1*5 mm thick have a good prognosis and in those with tumours thicker than 4 mm the prognosis is poor. In patients with neoplasms between 1 5 and 4 mm predictions based on thickness can be calculated as in Fig. 5 . Most authors agree that metastases are very uncommon in patients with primary melanomas less than 1 5 mm thick have a good prognosis and in extensive areas of regression are excluded. In these cases, measurement of the residual melanoma does not indicate thickness prior to regression, and is an unreliable indicator of clinical behaviour. 23 In this study, we used a Joyce Loebl "Magiscan" image analysis system which permitted rapid, reproducible measurements of tumour thickness and facilitated examination of a large number of slides. The same interactive technique may be used with a variety of cheaper optomanual instruments and is recommended but, an ocular micrometer can also be used and this is available to every pathologist at minimal cost.
Measurement of tumour thickness in malignant melanoma is a reliable guide to risk of tumour recurrence and death. It should be reported routinely by pathologists.
